A Phase 1b, Multicenter, Open-label Study of ACP-196 in Combination with Bendamustine and Rituximab (BR) in Subjects with Mantle Cell Lymphoma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 1b, Multicenter, Open-label Study of ACP-196 in Combination with Bendamustine and Rituximab (BR) in Subjects with Mantle Cell Lymphoma

Type of Cancer
Lymphoma
Locations
Hackensack
Sponsor
Acerta
Protocol Number
ACE-LY-106
Cancer Diagnosis
To Learn More Call
201-510-0910